Novabay Pharmaceuticals Inc. (NBY) NYSE MKT LLC

$0.68 -0.01 (-1.44%)

Market Cap: $2.86M

As of 06/09/23 04:00 PM EDT. Market closed.

(NBY)

Novabay Pharmaceuticals Inc. (NBY)
NYSE MKT LLC

$0.68
-0.01 (-1.44%)

Market Cap: $2.86M

As of 06/09/23 04:00 PM EDT. Market closed.

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing high-quality, differentiated, anti-infective consumer products: Avenova®, the premier antimicrobial lid and lash spray, CelleRx® Clinical Reset, a breakthrough product in the beauty category, and NeutroPhase® Skin and Wound Cleanser for wound healing. NovaBay's products are formulated with its patented, pure, stable, ... read more

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing high-quality, differentiated, anti-infective consumer products: Avenova®, the premier antimicrobial lid and lash spray, CelleRx® Clinical Reset, a breakthrough product in the beauty category, and NeutroPhase® Skin and Wound Cleanser for wound healing. NovaBay's products are formulated with its patented, pure, stable, pharmaceutical-grade hypochlorous acid that replicates the antimicrobial chemicals used by white blood cells to fight infection. NovaBay's hypochlorous acid products do not cause stinging or irritation, are non-toxic and non-sensitizing, making them completely safe for regular use. Avenova is the only commercial hypochlorous acid lid and lash spray product clinically proven to reduce bacterial load on ocular skin surfaces, thus effectively addressing the underlying cause of bacterial dry eye. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Justin Hall
Full Time Employees
33
URL
Address
2000 Powell St Ste 1150, California, Emeryville, 94608-1804.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Justin Hall
Full Time Employees
33
Address
2000 Powell St Ste 1150, California, Emeryville, 94608-1804.
PRICE CHART FOR NOVABAY PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0.68
Previous Close
$0.69
Days Range
$0.67 - $0.71
52 week range
$0.48 - $12.64
Volume
306,670
Avg. Volume (30 days)
1,215,057
Market Cap
$2.86M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
4,209,534
Open
$0.68
Previous Close
$0.69
Days Range
$0.67 - $0.71
52 week range
$0.48 - $12.64
Volume
306,670
Avg. Volume (30 days)
1,215,057
Market Cap
$2.86M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
4,209,534

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR NOVABAY PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Kunin AudreyChief Product OfficerDec 06, 2022 Sale$1.81120Dec 07, 2022, 04:55 PM
Kunin JeffreyPresident, DERMAdoctor, LLCDec 06, 2022 Sale$1.81120Dec 07, 2022, 04:55 PM
Kunin AudreyChief Product OfficerNov 21, 2022 Sale$2.105,96012,5451Dec 05, 2022, 05:30 PM
Kunin JeffreyPresident, DERMAdoctor, LLCNov 21, 2022 Sale$2.105,96012,5451Dec 05, 2022, 05:30 PM
Kunin AudreyChief Product OfficerNov 21, 2022 Sale$2.105,96012,5450Nov 23, 2022, 04:16 PM
Kunin JeffreyPresident, DERMAdoctor, LLCNov 21, 2022 Sale$2.105,96012,5450Nov 23, 2022, 04:15 PM
Hall JustinCEO, GC and DirectorSep 14, 2022 Buy$0.1510,0001,50083,172Sep 16, 2022, 08:45 PM
Kunin JeffreyPresident, DERMAdoctor, LLCSep 14, 2022 Sale$0.16291,36846,094208,632Sep 16, 2022, 06:26 PM
Kunin AudreyChief Product OfficerSep 14, 2022 Sale$0.16291,36846,094208,632Sep 16, 2022, 06:24 PM
Kunin JeffreyPresident, DERMAdoctor, LLCDec 03, 2021 Buy$0.46101,65047,013500,000Dec 07, 2021, 05:46 PM
Kunin AudreyChief Product OfficerDec 03, 2021 Buy$0.46101,65047,013500,000Dec 07, 2021, 05:43 PM
Hall JustinCEO, GC and DirectorDec 06, 2021 Buy$0.4369,76730,00073,172Dec 06, 2021, 08:03 PM
Kunin JeffreyPresident, DERMAdoctor, LLCDec 02, 2021 Buy$0.48262,369124,888398,350Dec 06, 2021, 04:31 PM
Kunin AudreyChief Product OfficerDec 02, 2021 Buy$0.48262,369124,888398,350Dec 06, 2021, 04:31 PM
Jones Andrew D.CFODec 06, 2021 Buy$0.4436,76516,177127,461Dec 06, 2021, 04:30 PM
Jones Andrew D.CFODec 03, 2021 Buy$0.448,6903,82490,696Dec 06, 2021, 04:30 PM
Kunin AudreyChief Product OfficerDec 01, 2021 Buy$0.4914,8487,276135,981Dec 03, 2021, 04:30 PM
Kunin JeffreyPresident, DERMAdoctor, LLCDec 01, 2021 Buy$0.4914,8487,276135,981Dec 03, 2021, 04:30 PM
Kunin JeffreyPresident, DERMAdoctor, LLCNov 30, 2021 Buy$0.4630,00013,800121,133Dec 02, 2021, 04:30 PM
Kunin AudreyChief Product OfficerNov 30, 2021 Buy$0.4630,00013,800121,133Dec 02, 2021, 04:30 PM
Kunin AudreyChief Product OfficerNov 23, 2021 Buy$0.4666,13330,36891,133Nov 24, 2021, 04:46 PM
Kunin AudreyChief Product OfficerNov 22, 2021 Buy$0.4625,00011,50025,000Nov 24, 2021, 04:46 PM
Kunin JeffreyPresident, DERMAdoctor, LLCNov 23, 2021 Buy$0.4666,13330,36891,133Nov 24, 2021, 04:46 PM
Kunin JeffreyPresident, DERMAdoctor, LLCNov 22, 2021 Buy$0.4625,00011,50025,000Nov 24, 2021, 04:46 PM
WU MIJIADirectorAug 17, 2020 Option Exercise$0.3020,0006,00020,000Aug 19, 2020, 04:24 PM
WU MIJIADirectorAug 17, 2020 Sale$1.3520,00027,0000Aug 19, 2020, 04:24 PM
Fu Jian Ping10% OwnerAug 01, 2020 Sale$1.231,302,3501,601,8914,000,000Aug 04, 2020, 06:04 PM
Raleigh Jason PhilipInterim CFO and TreasurerJun 11, 2019 Option Exercise$2.359,75022,9129,750Oct 28, 2019, 04:30 PM
Raleigh Jason PhilipInterim CFO and TreasurerJun 10, 2019 Option Exercise$2.2023,40551,49123,405Oct 28, 2019, 04:30 PM
Raleigh Jason PhilipInterim CFO and TreasurerJun 11, 2019 Sale$3.759,75036,5630Oct 28, 2019, 04:30 PM
Raleigh Jason PhilipInterim CFO and TreasurerJun 10, 2019 Sale$3.0023,40570,2150Oct 28, 2019, 04:30 PM
Hall JustinInterim President & CEO and GCJun 10, 2019 Option Exercise$2.0247,50095,95050,905Oct 28, 2019, 04:29 PM
Hall JustinInterim President & CEO and GCJun 10, 2019 Sale$3.0347,500143,9253,405Oct 28, 2019, 04:29 PM
Fu Jian Ping10% OwnerJun 11, 2019 Sale$3.84380,9541,462,8635,302,350Jun 13, 2019, 09:46 PM
Pioneer Pharma (Hong Kong) Co Ltd10% OwnerJun 11, 2019 Sale$4.0424,32698,2775,188,421Jun 13, 2019, 09:32 PM
WU MIJIADirectorJun 11, 2019 Sale$4.0415,87364,1270Jun 13, 2019, 06:03 AM
WU MIJIADirectorJun 10, 2019 Sale$2.0347,61996,6670Jun 13, 2019, 06:03 AM
Fu Jian Ping10% OwnerOct 11, 2016 Option Exercise$3.15126,985400,0033,983,304Oct 11, 2016, 06:44 PM
SIECZKAREK MARK MCEOSep 30, 2016 Option Exercise$1.91273,447522,284988,945Oct 03, 2016, 04:32 PM
WU MIJIADirectorSep 30, 2016 Option Exercise$3.1515,87350,00047,619Oct 03, 2016, 04:24 PM
Fu Jian Ping10% OwnerSep 22, 2016 Option Exercise$1.91968,5871,850,0013,856,319Sep 26, 2016, 06:14 PM
Pioneer Pharma (Singapore) Pte. Ltd.10% OwnerSep 22, 2016 Option Exercise$1.911,308,9022,500,0035,188,421Sep 26, 2016, 06:05 PM
Pioneer Pharma (Singapore) Pte. Ltd.10% OwnerSep 22, 2016 Option Exercise$1.81181,300328,1533,879,519Sep 26, 2016, 05:45 PM
Pioneer Pharma (Singapore) Pte. Ltd.10% OwnerAug 01, 2016 Option Exercise$1.911,308,9012,500,0013,698,219Aug 02, 2016, 01:26 PM
SIECZKAREK MARK MCEOAug 01, 2016 Option Exercise$1.91261,780500,000715,498Aug 02, 2016, 01:18 PM
Fu Jian Ping10% OwnerMay 09, 2016 Option Exercise$1.911,937,1733,700,0002,887,732May 16, 2016, 02:03 PM
Pioneer Pharma (Singapore) Pte. Ltd.10% OwnerMay 09, 2016 Option Exercise$1.911,308,9012,500,0012,389,318May 13, 2016, 05:17 PM
SIECZKAREK MARK MDirectorMay 09, 2016 Option Exercise$1.91261,780500,000453,718May 13, 2016, 02:55 PM
SIECZKAREK MARK MDirectorFeb 25, 2016 Option Exercise$1.91125,387239,489133,246Feb 26, 2016, 09:08 PM
Pioneer Pharma (Singapore) Pte. Ltd.10% OwnerFeb 25, 2016 Option Exercise$1.91696,5901,330,4871,104,742Feb 26, 2016, 09:07 PM
Najafi RaminChief Executive OfficerAug 20, 2015 Buy$0.446,0002,64012,000Aug 21, 2015, 04:03 PM
Najafi RaminChief Executive OfficerAug 19, 2015 Buy$0.506,0003,0006,000Aug 21, 2015, 04:03 PM
SIECZKAREK MARK MDirectorMar 03, 2015 Buy$0.60166,666100,000196,466Mar 05, 2015, 06:01 PM
Najafi RaminChief Executive OfficerMar 03, 2015 Buy$0.60166,666100,0003,391,666Mar 05, 2015, 05:44 PM
Pioneer Pharma (Singapore) Pte. Ltd.10% OwnerMar 03, 2015 Buy$0.602,590,0001,554,0009,595,656Mar 05, 2015, 05:01 PM
Stroman David W.SVP, Ophthalmic Product Devt.Dec 12, 2014 Buy$0.6610,0006,60023,000Dec 16, 2014, 10:05 AM
PAULSON THOMAS JCFODec 12, 2014 Buy$0.6810,0006,80068,210Dec 15, 2014, 01:14 PM
Najafi RaminChief Executive OfficerDec 12, 2014 Buy$0.6550,00032,5003,225,000Dec 15, 2014, 01:04 PM
PAULSON THOMAS JCFODec 09, 2014 Buy$0.6710,0006,70058,210Dec 11, 2014, 12:51 PM
Najafi RaminChief Executive OfficerDec 11, 2014 Buy$0.6020,00012,0003,175,000Dec 11, 2014, 12:43 PM
Najafi RaminChief Executive OfficerDec 05, 2014 Buy$0.6525,00016,2503,155,000Dec 08, 2014, 05:10 PM
Najafi RaminChief Executive OfficerDec 02, 2014 Buy$0.7118,00012,7803,130,000Dec 04, 2014, 05:15 PM
Wicks Tony D.S.DirectorDec 02, 2014 Sale$0.7020,00014,000213,660Dec 04, 2014, 04:52 PM
Wicks Tony D.S.DirectorDec 01, 2014 Sale$0.6910,0006,900213,680Dec 03, 2014, 04:56 PM
SIECZKAREK MARK MDirectorJun 04, 2014 Buy$0.894,8004,27229,800Jun 05, 2014, 07:53 PM
SIECZKAREK MARK MDirectorMay 19, 2014 Buy$0.8825,00022,00025,000May 21, 2014, 08:20 PM
China Pioneer Pharma Holdings Ltd10% OwnerMay 13, 2014 Buy$0.9965,06564,414608,156May 14, 2014, 05:22 PM
China Pioneer Pharma Holdings Ltd10% OwnerMay 12, 2014 Buy$0.99116,107114,946543,091May 14, 2014, 05:17 PM
China Pioneer Pharma Holdings Ltd10% OwnerMay 09, 2014 Buy$0.99318,828315,640426,984May 14, 2014, 05:10 PM
Wicks Tony D.S.DirectorApr 14, 2014 Option Exercise$0.5652,00029,120213,690Apr 14, 2014, 02:48 PM
Dailley AnthonyDirectorMar 17, 2014 Option Exercise$0.569,0005,040285,259Mar 21, 2014, 07:24 PM
China Pioneer Pharma Holdings Ltd10% OwnerDec 02, 2013 Buy$1.145,000,0005,700,0007,005,656Dec 04, 2013, 06:52 PM
Pioneer Pharma (Singapore) Pte. Ltd.10% OwnerDec 02, 2013 Buy$1.145,000,0005,700,0007,005,656Dec 04, 2013, 06:00 PM
Pioneer Pharma (Hong Kong) Co Ltd10% OwnerDec 02, 2013 Buy$1.145,000,0005,700,0007,005,656Dec 04, 2013, 05:59 PM
China Pioneer Pharma Holdings Ltd10% OwnerNov 14, 2013 Buy$1.02108,156110,319108,156Dec 02, 2013, 04:25 PM
Li Xinzhou10% OwnerSep 20, 2013 Sale$1.87120,000224,9880Dec 02, 2013, 02:42 PM
Najafi RaminChief Executive OfficerOct 28, 2013 Option Exercise$1.754,5577,975100,195Oct 29, 2013, 08:42 PM
PAULSON THOMAS JCFOOct 28, 2013 Option Exercise$1.753,6456,37963,855Oct 29, 2013, 08:27 PM
Li Xinzhou10% OwnerDec 11, 2012 Buy$1.20120,000144,0002,120,000Jan 03, 2013, 01:17 PM
Li Xinzhou10% OwnerOct 31, 2012 Buy$1.251,200,0001,500,0002,000,000Jan 02, 2013, 03:25 PM
Li Xinzhou10% OwnerSep 13, 2012 Buy$1.25800,0001,000,000800,000Jan 02, 2013, 03:17 PM
Stroman David W.SVP, Ophthalmic Product Devt.Dec 06, 2012 Buy$1.2410,00012,40022,000Dec 10, 2012, 08:17 PM
PAULSON THOMAS JCFODec 06, 2012 Buy$1.2410,00012,40063,855Dec 10, 2012, 08:06 PM
Najafi RaminChief Executive OfficerDec 06, 2012 Buy$1.2420,00024,800100,195Dec 10, 2012, 08:01 PM
PAULSON THOMAS JCFOOct 27, 2012 Option Exercise$1.313,6454,77553,855Dec 04, 2012, 01:50 PM
Najafi RaminChief Executive OfficerOct 27, 2012 Option Exercise$1.314,5575,97080,195Dec 04, 2012, 01:50 PM
NAQU AREA PIONEER PHARMA CO., LTD.10% OwnerOct 31, 2012 Buy$1.251,200,0001,500,0002,000,000Nov 20, 2012, 02:14 PM
Pioneer Pharma (Singapore) Pte. Ltd.10% OwnerOct 31, 2012 Buy$1.251,200,0001,500,0002,000,000Nov 05, 2012, 02:12 PM
Tufts Robert R.DirectorSep 27, 2012 Option Exercise$0.5628,50015,960348,408Nov 01, 2012, 07:35 PM
PAULSON THOMAS JCFOMay 30, 2012 Buy$0.9410,0009,36417,500May 31, 2012, 06:27 PM
Najafi RaminChief Executive OfficerMay 29, 2012 Buy$0.966,0005,75634,752May 30, 2012, 04:52 PM
Najafi RaminChief Executive OfficerMay 25, 2012 Buy$0.993,5003,46528,752May 29, 2012, 02:09 PM
Freiman Paul E.DirectorDec 29, 2011 Option Exercise$0.2030,0006,00045,137Jan 05, 2012, 04:19 PM
Najafi RaminChief Executive OfficerOct 27, 2011 Option Exercise$1.0950,00054,500202,673Nov 01, 2011, 06:24 PM
PAULSON THOMAS JCFOOct 27, 2011 Option Exercise$1.0940,00043,60040,000Nov 01, 2011, 06:02 PM
Najafi RaminChief Executive OfficerSep 29, 2011 Option Exercise$0.90152,673137,406177,925Oct 03, 2011, 04:04 PM
Freiman Paul E.DirectorSep 12, 2011 Buy$0.843,0002,52015,137Sep 13, 2011, 07:52 PM
PAULSON THOMAS JCFOAug 26, 2011 Buy$0.863,5003,0107,500Aug 29, 2011, 02:20 PM
Najafi RaminChief Executive OfficerAug 16, 2011 Buy$0.8510,0008,50025,252Aug 16, 2011, 07:40 PM
Tufts Robert R.DirectorAug 15, 2011 Buy$0.855,0004,242319,908Aug 16, 2011, 04:37 PM
Najafi RaminChief Executive OfficerMay 27, 2011 Buy$1.5950079715,252May 31, 2011, 03:55 PM
Khosrovi BehzadVP Research and DevelopmentMay 27, 2011 Buy$1.641,0001,644136,000May 31, 2011, 03:53 PM
McPherson T. AlexDirectorMay 27, 2011 Buy$1.656,20010,2176,700May 27, 2011, 04:38 PM
Najafi RaminChief Executive OfficerMay 26, 2011 Buy$1.601,0001,59714,752May 27, 2011, 12:08 PM
Najafi RaminChief Executive OfficerMay 24, 2011 Buy$1.712,5524,37113,752May 26, 2011, 05:03 PM
Najafi RaminChief Executive OfficerSep 02, 2008 Buy$1.981,0001,9807,200Feb 01, 2011, 06:01 PM
Freiman Paul E.DirectorAug 16, 2010 Sale$1.8315,00027,45012,137Aug 18, 2010, 01:46 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Kunin AudreyChief Product Officer12/06/20222
Kunin JeffreyPresident, DERMAdoctor, LLC12/06/20222
Kunin AudreyChief Product Officer11/21/202212,545
Kunin JeffreyPresident, DERMAdoctor, LLC11/21/202212,545
Kunin AudreyChief Product Officer11/21/202212,545
Kunin JeffreyPresident, DERMAdoctor, LLC11/21/202212,545
Hall JustinCEO, GC and Director09/14/20221,500
Kunin JeffreyPresident, DERMAdoctor, LLC09/14/202246,094
Kunin AudreyChief Product Officer09/14/202246,094
Kunin JeffreyPresident, DERMAdoctor, LLC12/03/202147,013
Kunin AudreyChief Product Officer12/03/202147,013
Hall JustinCEO, GC and Director12/06/202130,000
Kunin JeffreyPresident, DERMAdoctor, LLC12/02/2021124,888
Kunin AudreyChief Product Officer12/02/2021124,888
Jones Andrew D.CFO12/06/202116,177
Jones Andrew D.CFO12/03/20213,824
Kunin AudreyChief Product Officer12/01/20217,276
Kunin JeffreyPresident, DERMAdoctor, LLC12/01/20217,276
Kunin JeffreyPresident, DERMAdoctor, LLC11/30/202113,800
Kunin AudreyChief Product Officer11/30/202113,800
Kunin AudreyChief Product Officer11/23/202130,368
Kunin AudreyChief Product Officer11/22/202111,500
Kunin JeffreyPresident, DERMAdoctor, LLC11/23/202130,368
Kunin JeffreyPresident, DERMAdoctor, LLC11/22/202111,500
WU MIJIADirector08/17/20206,000
WU MIJIADirector08/17/202027,000
Fu Jian Ping10% Owner08/01/20201,601,891
Raleigh Jason PhilipInterim CFO and Treasurer06/11/201922,912
Raleigh Jason PhilipInterim CFO and Treasurer06/10/201951,491
Raleigh Jason PhilipInterim CFO and Treasurer06/11/201936,563
Raleigh Jason PhilipInterim CFO and Treasurer06/10/201970,215
Hall JustinInterim President & CEO and GC06/10/201995,950
Hall JustinInterim President & CEO and GC06/10/2019143,925
Fu Jian Ping10% Owner06/11/20191,462,863
Pioneer Pharma (Hong Kong) Co Ltd10% Owner06/11/201998,277
WU MIJIADirector06/11/201964,127
WU MIJIADirector06/10/201996,667
Fu Jian Ping10% Owner10/11/2016400,003
SIECZKAREK MARK MCEO09/30/2016522,284
WU MIJIADirector09/30/201650,000
Fu Jian Ping10% Owner09/22/20161,850,001
Pioneer Pharma (Singapore) Pte. Ltd.10% Owner09/22/20162,500,003
Pioneer Pharma (Singapore) Pte. Ltd.10% Owner09/22/2016328,153
Pioneer Pharma (Singapore) Pte. Ltd.10% Owner08/01/20162,500,001
SIECZKAREK MARK MCEO08/01/2016500,000
Fu Jian Ping10% Owner05/09/20163,700,000
Pioneer Pharma (Singapore) Pte. Ltd.10% Owner05/09/20162,500,001
SIECZKAREK MARK MDirector05/09/2016500,000
SIECZKAREK MARK MDirector02/25/2016239,489
Pioneer Pharma (Singapore) Pte. Ltd.10% Owner02/25/20161,330,487
Najafi RaminChief Executive Officer08/20/20152,640
Najafi RaminChief Executive Officer08/19/20153,000
SIECZKAREK MARK MDirector03/03/2015100,000
Najafi RaminChief Executive Officer03/03/2015100,000
Pioneer Pharma (Singapore) Pte. Ltd.10% Owner03/03/20151,554,000
Stroman David W.SVP, Ophthalmic Product Devt.12/12/20146,600
PAULSON THOMAS JCFO12/12/20146,800
Najafi RaminChief Executive Officer12/12/201432,500
PAULSON THOMAS JCFO12/09/20146,700
Najafi RaminChief Executive Officer12/11/201412,000
Najafi RaminChief Executive Officer12/05/201416,250
Najafi RaminChief Executive Officer12/02/201412,780
Wicks Tony D.S.Director12/02/201414,000
Wicks Tony D.S.Director12/01/20146,900
SIECZKAREK MARK MDirector06/04/20144,272
SIECZKAREK MARK MDirector05/19/201422,000
China Pioneer Pharma Holdings Ltd10% Owner05/13/201464,414
China Pioneer Pharma Holdings Ltd10% Owner05/12/2014114,946
China Pioneer Pharma Holdings Ltd10% Owner05/09/2014315,640
Wicks Tony D.S.Director04/14/201429,120
Dailley AnthonyDirector03/17/20145,040
China Pioneer Pharma Holdings Ltd10% Owner12/02/20135,700,000
Pioneer Pharma (Singapore) Pte. Ltd.10% Owner12/02/20135,700,000
Pioneer Pharma (Hong Kong) Co Ltd10% Owner12/02/20135,700,000
China Pioneer Pharma Holdings Ltd10% Owner11/14/2013110,319
Li Xinzhou10% Owner09/20/2013224,988
Najafi RaminChief Executive Officer10/28/20137,975
PAULSON THOMAS JCFO10/28/20136,379
Li Xinzhou10% Owner12/11/2012144,000
Li Xinzhou10% Owner10/31/20121,500,000
Li Xinzhou10% Owner09/13/20121,000,000
Stroman David W.SVP, Ophthalmic Product Devt.12/06/201212,400
PAULSON THOMAS JCFO12/06/201212,400
Najafi RaminChief Executive Officer12/06/201224,800
PAULSON THOMAS JCFO10/27/20124,775
Najafi RaminChief Executive Officer10/27/20125,970
NAQU AREA PIONEER PHARMA CO., LTD.10% Owner10/31/20121,500,000
Pioneer Pharma (Singapore) Pte. Ltd.10% Owner10/31/20121,500,000
Tufts Robert R.Director09/27/201215,960
PAULSON THOMAS JCFO05/30/20129,364
Najafi RaminChief Executive Officer05/29/20125,756
Najafi RaminChief Executive Officer05/25/20123,465
Freiman Paul E.Director12/29/20116,000
Najafi RaminChief Executive Officer10/27/201154,500
PAULSON THOMAS JCFO10/27/201143,600
Najafi RaminChief Executive Officer09/29/2011137,406
Freiman Paul E.Director09/12/20112,520
PAULSON THOMAS JCFO08/26/20113,010
Najafi RaminChief Executive Officer08/16/20118,500
Tufts Robert R.Director08/15/20114,242
Najafi RaminChief Executive Officer05/27/2011797
Khosrovi BehzadVP Research and Development05/27/20111,644
McPherson T. AlexDirector05/27/201110,217
Najafi RaminChief Executive Officer05/26/20111,597
Najafi RaminChief Executive Officer05/24/20114,371
Najafi RaminChief Executive Officer09/02/20081,980
Freiman Paul E.Director08/16/201027,450
Load More Insider Transactions
FUNDS WITH A POSITION IN NOVABAY PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC18,7230.00004%7.46%Other
BLACKROCK INC.200%-4.76%Other